Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,330.00
Bid: 12,328.00
Ask: 12,332.00
Change: -68.00 (-0.55%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,482.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Wed, 30th Jul 2014 15:27

UK Earnings, Trading Statements Calendar 
Thursday, July 31 
AstraZenecaHalf Year Results
CommunisisFull Year Results
F&C Asset ManagementFull Year Results
Rolls-Royce HoldingsHalf Year Results
Thomas Cook GroupInterim Management Statement
Merlin EntertainmentsHalf Year Results
Intu PropertiesHalf Year Results
Royal Dutch ShellQ2 Results
Centaur MediaHalf Year Results
Promethean WorldHalf Year Results
Lloyds Banking GroupHalf Year Results
InvestecHalf Year Results
LairdHalf Year Results
XchangingHalf Year Results
DiageoFull Year Results
Greencoat UK WindHalf Year Results
EssentraHalf Year Results
Millennium & Copthorne HotelsHalf Year Results
BodycoteHalf Year Results
BT GroupQ1 Results
Colt GroupQ2 Results
KazakhmysQ2 Results
TorotrakInterim Management Statement
BG GroupHalf Year Results
CrestonInterim Management Statement
Weir GroupHalf Year Results
CentricaHalf Year Results
BAE SystemsHalf Year Results
CountrywideHalf Year Results
Management Consulting GroupHalf Year Results
RPS GroupHalf Year Results
Spirent CommunicationsHalf Year Results
InchcapeHalf Year Results
SchrodersHalf Year Results
TSB Banking GroupHalf Year Results
Friday, August 1 
Direct Line Insurance GroupHalf Year Results
Capital & Counties PropertiesHalf Year Results
Smith & NephewHalf Year Results
UBMHalf Year Results
Man GroupHalf Year Results
RexamHalf Year Results
VesuviusHalf Year Results
William HillHalf Year Results
Rentokil InitialHalf Year Results
IMIHalf Year Results
Robert WaltersHalf Year Results
Royal Bank of Scotland Group (finalised)Half Year Results
Monday, August 4 
SeniorHalf Year Results
Telecity GroupHalf Year Results
esure GroupHalf Year Results
Immunodiagnostic Systems HldgsTrading Statement
Fidessa GroupHalf Year Results
Intertek GroupHalf Year Results
Keller GroupHalf Year Results
AlentHalf Year Results
HSBC HoldingsHalf Year Results
Morgan Sindall GroupHalf Year Results
Ultra Electronics HoldingsHalf Year Results
Tribal GroupHalf Year Results
AfrenHalf Year Results
Tuesday, August 5 
Hill & Smith HoldingsHalf Year Results
LSL Property ServicesHalf Year Results
VernalisHalf Year Results
Genel EnergyHalf Year Results
AggrekoHalf Year Results
888 HoldingsTrading Statement
InmarsatHalf Year Results
BBA AviationHalf Year Results
T ClarkeHalf Year Results
FresnilloHalf Year Results
InterContinental Hotels GroupHalf Year Results
MeggittHalf Year Results
RotorkHalf Year Results
SDLHalf Year Results
Novae GroupHalf Year Results
Avocet MiningHalf Year Results
Standard LifeHalf Year Results
S&UTrading Statement
Wednesday, August 6 
Friends Life GroupHalf Year Results
Standard CharteredHalf Year Results
GW PharmaceuticalsHalf Year Results
Legal & General GroupHalf Year Results
FerrexpoHalf Year Results
GraingerInterim Management Statement
InterserveHalf Year Results
StatproHalf Year Results
Johnston PressHalf Year Results
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslodex, for the treatment of a form of breast cancer.

Read more
18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

Read more
18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with inflation data and central bank decisions the key plot points as the week progresses.

Read more
18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with paclitaxel did not achieve its primary endpoints.

Read more
17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "important new option" for patients.

Read more
17 Jun 2024 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Bank of England.

Read more
17 Jun 2024 07:23

IN BRIEF: AstraZeneca gets positive cancer test results for Calquence

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III trial shows that Calquence, when used in combination with bendamustine and rituximab, demonstrates a clinically meaningful improvement in progression-free survival in patients with untreated mantle cell lymphoma. Compared to standard-of-care chemoimmunotherapy, the combination with Calquence, whose generic name is acalabrutinib, shows a 27% reduced risk of disease progression or death. Mantle cell lymphoma is rare and typically aggressive form of non-Hodgkin lymphoma, Astra explains.

Read more
17 Jun 2024 07:15

AstraZeneca's Imfinzi gets US approval for endometrial cancer patients

(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.

Read more
12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

Read more
10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of non-small cell lung cancer.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.